TY - JOUR
T1 - A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19
T2 - CCC19 Governance, Protocol, and Quality Assurance
AU - The COVID-19 and Cancer Consortium
AU - Abidi, Maheen
AU - Aboulafia, David M.
AU - Accordino, Melissa K.
AU - Acoba, Jared D.
AU - Ahluwalia, Manmeet S.
AU - Ahmad, Syed A.
AU - Ajmera, Archana
AU - Alimohamed, Saif I.
AU - Altman, Jessica
AU - Angevine, Anne H.
AU - Bakouny, Ziad
AU - Bar, Michael H.
AU - Bardia, Aditya
AU - Barnholtz-Sloan, Jill S.
AU - Barrow McCollough, Briana
AU - Bashir, Babar
AU - Batist, Gerald
AU - Bekaii-Saab, Tanios S.
AU - Berg, Stephanie
AU - Bernicker, Eric H.
AU - Bhutani, Divaya
AU - Bilen, Mehmet A.
AU - Bindal, Poorva
AU - Bishnoi, Rohit
AU - Blau, Sibel
AU - Bohachek, Pamela
AU - Boland, Genevieve
AU - Bonnen, Mark
AU - Bouchard, Gabrielle
AU - Bouganim, Nathaniel
AU - Bowles, Daniel W.
AU - Busser, Fiona J.
AU - Butt, Omar
AU - Cabal, Angelo
AU - Cabalona, Wilhelmina D.
AU - Cabebe, Elwyn C.
AU - Caimi, Paolo
AU - Campian, Jian L.
AU - Carducci, Theresa M.
AU - Chen, James L.
AU - Cheng, Alex
AU - Chism, David D.
AU - Choueiri, Toni K.
AU - Clark, Melanie J.
AU - Clement, Jessica M.
AU - Connors, Jean M.
AU - Cook, Erin
AU - Curran, Catherine R.
AU - Halfdanarson, Thorvardur R.
AU - Mesa, Ruben A.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/12/14
Y1 - 2020/12/14
N2 - When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 institutions with >400 collaborators. More than 5,000 cases with complete baseline data have been accrued. Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments.
AB - When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 institutions with >400 collaborators. More than 5,000 cases with complete baseline data have been accrued. Future directions include increased electronic health record integration for direct data ingestion, expansion to additional domestic and international sites, more intentional patient involvement, and granular analyses of still-unanswered questions related to cancer subtypes and treatments.
UR - http://www.scopus.com/inward/record.url?scp=85098602495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098602495&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2020.10.022
DO - 10.1016/j.ccell.2020.10.022
M3 - Comment/debate
C2 - 33176160
AN - SCOPUS:85098602495
SN - 1535-6108
VL - 38
SP - 761
EP - 766
JO - Cancer cell
JF - Cancer cell
IS - 6
ER -